Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy
- Resource Type
- Article
- Authors
- Wong, Boaz; Bergeron, Anabel; Maznyi, Glib; Ng, Kristy; Jirovec, Anna; Birdi, Harsimrat K.; Serrano, Daniel; Spinelli, Marcus; Thomson, Max; Taha, Zaid; Alwithenani, Akram; Chen, Andrew; Lorimer, Ian; Vanderhyden, Barbara; Arulanandam, Rozanne; Diallo, Jean-Simon
- Source
- In Molecular Therapy 1 November 2023 31(11):3176-3192
- Subject
- Language
- ISSN
- 1525-0016